-
<![CDATA[Cadonilimab Plus Chemo Retains Clinically Meaningful Survival Advantage in Frontline Gastric/GEJ Adenocarcinoma ]]>
23 Oct 2025 18:05 GMT
… gastric or gastroesophageal junction (GEJ) adenocarcinoma regardless of PD-L1 expression … junction (G/GEJ) adenocarcinoma: final results of the phase … advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, …
-
Rare case of pancreatic Hodgkin lymphoma is often misdiagnosed as pancreatic adenocarcinoma
22 Oct 2025 18:16 GMT
… , initially raising concern for pancreatic adenocarcinoma, the most common type of … condition often misdiagnosed as pancreatic adenocarcinoma or pseudocyst."
A lymph …
-
GSDMC: New Target for Pancreatic Adenocarcinoma Therapy
20 Oct 2025 22:27 GMT
… treatment efficacy in pancreatic adenocarcinoma. By inducing pyroptosis, … Keywords: GSDMC, pyroptosis, pancreatic adenocarcinoma, cancer therapy, tumor microenvironment … cancer researchGSDMC in pancreatic adenocarcinoma therapyidentifying therapeutic targets …
-
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
20 Oct 2025 12:00 GMT
… Patients with Treatment Refractory Metastatic Adenocarcinoma” at the European Society for … therapy for patients with advanced adenocarcinoma. BA3182 is a (CAB) EpCAM … efficacy of BA3182 in advanced adenocarcinoma patients. About CAB technology
CAB …
-
2024 First Generic Drug Approvals
23 Oct 2025 18:33 GMT
… myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of ovary, retinoblastoma, breast carcinoma …
-
MALAT1’s m6A Modification by METTL3 Promotes Pyroptosis and Inflammation in Sepsis-Induced Acute Kidney Injury in Mice
23 Oct 2025 16:08 GMT
… Among them, metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been …
-
RNF43 Targets Phosphorylated E-Cadherin Degradation
23 Oct 2025 12:40 GMT
… epithelial-mesenchymal transition in lung adenocarcinoma, focusing on the ubiquitination and … tumor progressionepithelial-mesenchymal transition mechanismslung adenocarcinoma researchphosphorylated E-cadherin degradationproteasomal degradation …
-
Innovent Biologics & Takeda Pharma ink collaboration to accelerate the development of next-generation I/O and ADC therapies to the global market
23 Oct 2025 12:29 GMT
… in previously treated pancreatic ductal adenocarcinoma (PDAC) has been completed. This …
-
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
23 Oct 2025 12:00 GMT
… a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis …
-
Innovent Biologics inks Global Strategic pact with Takeda to advance next generation IO, ADC cancer therapies
23 Oct 2025 10:21 GMT
… in previously treated pancreatic ductal adenocarcinoma (PDAC) and has received Breakthrough … unresectable or metastatic pancreatic ductal adenocarcinoma (PDAC) that has relapsed and …
About
© 1995-2025